Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-24

Clinical Trial Update: Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing efficacy of QVAR versus Flovent Diskus on small airways in poorly controlled asthmatic adolescents and adults; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flovent Diskus (fluticasone propionate)
  • QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 4 | Status: TERMINATED